Global Health Is In Disarray – But Is A Pandemic Treaty The Way Out ? 23/04/2021 Svĕt Lustig Vijay Despite rising calls for a pandemic treaty, including from 25 world leaders in an open letter last month, some global health experts doubt that a treaty would be the most efficient way to quickly strengthen the world’s capacity to beat COVID – and prevent future pandemics. “I don’t think we have time to negotiate another […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> Treatment To Prevent Malaria in Pregnancy Is Making A Big Difference In Kenya’s Kilifi County – Elyne’s Story 24/07/2020 Geoffrey Kamadi Kilifi County, Kenya – Elyne Kaingu, a 33-year old mother from the beautiful Mnarani area of Kilifi County, overlooking the Indian Ocean, was extremely wary during her first pregnancy about the silent killer in her midst – malaria. She knew some other first time mothers had fallen ill with the disease, and had even lost […] Continue reading -> World Health Assembly Events Series Kicks Off Thursday 13/05/2020 Editorial team Health Policy Watch is the media partner for the Geneva Graduate Institute – Global Health Centre series of World Health Assembly events, running Thursday 14 May to Wednesday 27 May. The series of events is built around themes relevant to the 73rd session of the WHA, 18-19 May, the first ever Assembly to bring together the World […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> Treatment To Prevent Malaria in Pregnancy Is Making A Big Difference In Kenya’s Kilifi County – Elyne’s Story 24/07/2020 Geoffrey Kamadi Kilifi County, Kenya – Elyne Kaingu, a 33-year old mother from the beautiful Mnarani area of Kilifi County, overlooking the Indian Ocean, was extremely wary during her first pregnancy about the silent killer in her midst – malaria. She knew some other first time mothers had fallen ill with the disease, and had even lost […] Continue reading -> World Health Assembly Events Series Kicks Off Thursday 13/05/2020 Editorial team Health Policy Watch is the media partner for the Geneva Graduate Institute – Global Health Centre series of World Health Assembly events, running Thursday 14 May to Wednesday 27 May. The series of events is built around themes relevant to the 73rd session of the WHA, 18-19 May, the first ever Assembly to bring together the World […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Treatment To Prevent Malaria in Pregnancy Is Making A Big Difference In Kenya’s Kilifi County – Elyne’s Story 24/07/2020 Geoffrey Kamadi Kilifi County, Kenya – Elyne Kaingu, a 33-year old mother from the beautiful Mnarani area of Kilifi County, overlooking the Indian Ocean, was extremely wary during her first pregnancy about the silent killer in her midst – malaria. She knew some other first time mothers had fallen ill with the disease, and had even lost […] Continue reading -> World Health Assembly Events Series Kicks Off Thursday 13/05/2020 Editorial team Health Policy Watch is the media partner for the Geneva Graduate Institute – Global Health Centre series of World Health Assembly events, running Thursday 14 May to Wednesday 27 May. The series of events is built around themes relevant to the 73rd session of the WHA, 18-19 May, the first ever Assembly to bring together the World […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
World Health Assembly Events Series Kicks Off Thursday 13/05/2020 Editorial team Health Policy Watch is the media partner for the Geneva Graduate Institute – Global Health Centre series of World Health Assembly events, running Thursday 14 May to Wednesday 27 May. The series of events is built around themes relevant to the 73rd session of the WHA, 18-19 May, the first ever Assembly to bring together the World […] Continue reading -> Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Malaria in Pregnancy – MMV Makes Renewed Efforts To Protect This High-Risk Group 01/05/2020 Elaine Ruth Fletcher & Grace Ren Reducing new cases of malaria among pregnant women remains one of the key challenges on the road to malaria elimination – a goal that was celebrated last week, on World Malaria Day, 25 April. Although malaria deaths fell by nearly a quarter between 2010 and 2018, pregnant women remain among the groups most at risk […] Continue reading -> Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Behind The Scenes Of The MMV Story – From Coartem Dispersible’s ‘Opening Act’ To A New Drug For Relapsing Malaria 23/11/2019 Editorial team Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Write a Comment... Email (Required) Name (Required) Website Loading Comments... Comment ×
Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis 11/10/2019 John Zarocostas Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading -> Posts navigation Older posts